Published in Am J Ophthalmol on June 10, 2008
25-, 23-, and 20-gauge vitrectomy in epiretinal membrane surgery: a comparative study of 553 cases. Graefes Arch Clin Exp Ophthalmol (2011) 1.13
Adverse events after pars plana vitrectomy among medicare beneficiaries. Arch Ophthalmol (2009) 0.94
Primary 23-gauge sutureless vitrectomy for rhegmatogenous retinal detachment. Indian J Ophthalmol (2012) 0.94
Comparison of postoperative intraocular pressure changes between 23-gauge transconjunctival sutureless vitrectomy and conventional 20-gauge vitrectomy. Eye (Lond) (2012) 0.92
Intraoperative iatrogenic peripheral retinal break in 23-gauge transconjunctival sutureless vitrectomy versus 20-gauge conventional vitrectomy. Graefes Arch Clin Exp Ophthalmol (2013) 0.84
Use of systemic steroid after successful macular surgery in eyes with epiretinal membrane: a randomized, controlled clinical study. Eye (Lond) (2011) 0.80
23- vs 20-gauge pars plana vitrectomy in combination with bimanual microincisional cataract surgery (b-MICS) for the treatment of macular hole and cataract as a one-step procedure. Eye (Lond) (2013) 0.79
Comparison of efficacy and safety between transconjunctival 23-gauge and conventional 20-gauge vitrectomy systems in macular surgery. Korean J Ophthalmol (2012) 0.77
Short-term outcomes of 23-gauge pars plana vitrectomy. Am J Ophthalmol (2008) 0.76
In vivo comparison of 23- and 25-gauge sutureless vitrectomy incision architecture using spectral domain optical coherence tomography. J Ophthalmol (2013) 0.75
Segmentation and removal of fibrovascular membranes with high-speed 23 G transconjunctival sutureless vitrectomy, in severe proliferative diabetic retinopathy. Clin Ophthalmol (2016) 0.75
A modified approach to actively remove high viscosity silicone oil through 23-gauge cannula. Int J Ophthalmol (2016) 0.75
Conjunctival pigmentation after 23-gauge microincisional vitrectomy surgery. Eye (Lond) (2011) 0.75
Perioperative changes of the intraocular pressure during the treatment of epiretinal membrane by using 25- or 27-gauge sutureless vitrectomy without gas tamponade. Clin Ophthalmol (2017) 0.75
Polyethylene Glycol-Based Synthetic Hydrogel Sealant for Closing Vitrectomy Wounds: An In Vivo and Histological Study. Transl Vis Sci Technol (2016) 0.75
Suprachoroidal gas injection as a complication of pars plana vitrectomy confirmed by computed tomography. Clin Ophthalmol (2012) 0.75
Evaluation of mechanical closure resistance of sutureless vitrectomy sclerotomies after conjunctival cauterization with bipolar diathermy forceps. Graefes Arch Clin Exp Ophthalmol (2015) 0.75
Risk factors for suture requirement and early hypotony in 23-gauge vitrectomy for complex vitreoretinal diseases. Int Ophthalmol (2016) 0.75
Ranibizumab for neovascular age-related macular degeneration. N Engl J Med (2006) 30.63
Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med (2006) 20.84
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. Lancet (2010) 19.74
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology (2012) 8.29
Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. Ophthalmology (2009) 6.44
Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol (2003) 4.78
Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. J Clin Oncol (2003) 4.34
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology (2010) 3.49
Interim results from the international trial of Second Sight's visual prosthesis. Ophthalmology (2012) 3.35
Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina (2011) 3.04
The artificial silicon retina microchip for the treatment of vision loss from retinitis pigmentosa. Arch Ophthalmol (2004) 2.89
Evidence-based National Vaccine Policy. Indian J Med Res (2010) 2.75
Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina (2008) 2.72
A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration clinical and economic impact. Ophthalmology (2010) 2.67
Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology (2011) 2.65
Oct-based interpretation of the vitreomacular interface and indications for pharmacologic vitreolysis. Retina (2013) 2.49
The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology (2013) 2.35
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema. Ophthalmology (2012) 2.32
Short-term outcomes of 25-gauge vitrectomy with silicone oil for repair of complicated retinal detachment. Retina (2008) 2.28
Evaluation of wound closure in oblique 23-gauge sutureless sclerotomies with visante optical coherence tomography. Am J Ophthalmol (2008) 2.26
A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 1. Visual function and structural outcome. Ophthalmology (2002) 2.16
Utility of intraoperative optical coherence tomography during vitrectomy surgery for vitreomacular traction syndrome. Retina (2014) 2.15
High-power, computer-controlled, light-emitting diode-based light sources for fluorescence imaging and image-guided surgery. Mol Imaging (2009) 2.15
Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration. Ophthalmology (2013) 2.13
Characteristics of endophthalmitis in patients with the Boston keratoprosthesis. Cornea (2009) 2.09
Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema. Am J Ophthalmol (2005) 1.99
Intrasurgical dynamics of macular hole surgery: an assessment of surgery-induced ultrastructural alterations with intraoperative optical coherence tomography. Retina (2014) 1.97
Novel microarchitectural dynamics in rhegmatogenous retinal detachments identified with intraoperative optical coherence tomography. Retina (2013) 1.96
Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center. Medicine (Baltimore) (2003) 1.94
Optical coherence tomography enhanced depth imaging of choroidal tumors. Am J Ophthalmol (2011) 1.91
Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome. Br J Ophthalmol (2013) 1.86
Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration. Ophthalmology (2009) 1.86
Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy. Am J Ophthalmol (2003) 1.74
Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Retina (2007) 1.68
Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. Am J Ophthalmol (2007) 1.65
Comparison of topical anesthetics for intravitreal injections : a randomized clinical trial. Retina (2012) 1.63
Panretinal photocoagulation for proliferative diabetic retinopathy: pattern scan laser versus argon laser. Am J Ophthalmol (2011) 1.62
Optical coherence tomography 3: Automatic delineation of the outer neural retinal boundary and its influence on retinal thickness measurements. Invest Ophthalmol Vis Sci (2004) 1.62
Optical coherence tomographic patterns of diabetic macular edema. Am J Ophthalmol (2006) 1.62
Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology (2008) 1.60
Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina (2003) 1.60
Association of educational, occupational and socioeconomic status with cardiovascular risk factors in Asian Indians: a cross-sectional study. PLoS One (2012) 1.53
Comparison of spectral-domain versus time-domain optical coherence tomography in management of age-related macular degeneration with ranibizumab. Ophthalmology (2009) 1.52
Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema. Ophthalmology (2013) 1.52
Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology. Ophthalmology (2008) 1.47
Adverse events after intravitreal triamcinolone in patients with and without uveitis. Ophthalmology (2007) 1.45
Prevalence of outer retinal tubulation after anti-VEGF therapy for age-related macular degeneration. Ophthalmic Surg Lasers Imaging Retina (2015) 1.42
Is coxsackievirus the cause of unilateral acute idiopathic maculopathy? Arch Ophthalmol (2004) 1.41
Gestational diabetes mellitus--Indian guidelines. J Indian Med Assoc (2009) 1.40
Neovascular age-related macular degeneration: potential therapies. Drugs (2008) 1.38
Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection. Ophthalmic Surg Lasers Imaging (2005) 1.38
Metallic intraocular foreign bodies: characteristics, interventions, and prognostic factors for visual outcome and globe survival. Am J Ophthalmol (2008) 1.37
Gestational diabetes mellitus--guidelines. J Assoc Physicians India (2006) 1.35
Small-gauge pars plana vitrectomy: a report by the American Academy of Ophthalmology. Ophthalmology (2010) 1.32
Aflibercept for age-related macular degeneration: a game-changer or quiet addition? Am J Ophthalmol (2012) 1.31
Ciprofloxacin-resistant Neisseria meningitidis, Delhi, India. Emerg Infect Dis (2007) 1.28
Bevacizumab for neovascular age-related macular degeneration using a treat-and-extend regimen: clinical and economic impact. Am J Ophthalmol (2011) 1.28
A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 2. Refractive outcome. Ophthalmology (2002) 1.26
Macular pucker removal with and without internal limiting membrane peeling: pilot study. Ophthalmology (2003) 1.26
Prevalence of gestational diabetes mellitus (GDM) and its outcomes in Jammu region. J Assoc Physicians India (2011) 1.25
Management of submacular hemorrhage. Ophthalmol Clin North Am (2002) 1.24
Nipah/Hendra virus outbreak in Siliguri, West Bengal, India in 2001. Indian J Med Res (2006) 1.21
Association between high-risk disease loci and response to anti-vascular endothelial growth factor treatment for wet age-related macular degeneration. Retina (2012) 1.19
Risk factors for choroidal neovascularization and vision loss in the fellow eye study of CNVPT. Retina (2003) 1.18
Changing trends in the microbiologic aspects of postcataract endophthalmitis. Arch Ophthalmol (2005) 1.17
Evaluation of choroidal thickness in retinitis pigmentosa using enhanced depth imaging optical coherence tomography. Br J Ophthalmol (2012) 1.17
Pars plana vitrectomy versus combined pars plana vitrectomy-scleral buckle for primary repair of pseudophakic retinal detachment. Ophthalmology (2006) 1.17
Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina (2014) 1.15
Postoperative complications associated with 25-gauge pars plana vitrectomy. Ophthalmic Surg Lasers Imaging (2007) 1.15
A novel segmentation algorithm for volumetric analysis of macular hole boundaries identified with optical coherence tomography. Invest Ophthalmol Vis Sci (2013) 1.13
Verteporfin photodynamic therapy of six eyes with retinal capillary haemangioma. Acta Ophthalmol (2010) 1.12
Intravitreal bevacizumab (avastin) in central retinal vein occlusion. Retina (2007) 1.10
A phase 1 study of KH902, a vascular endothelial growth factor receptor decoy, for exudative age-related macular degeneration. Ophthalmology (2010) 1.10
Cytomegalovirus retinitis after fluocinolone acetonide (Retisert) implant. Am J Ophthalmol (2006) 1.09
Pregnancy associated aplastic anemia--a series of 10 cases with review of literature. Hematology (2002) 1.07
Life-threatening motor neurotoxicity in association with bortezomib. Haematologica (2006) 1.07
Contrast-enhanced intraoperative optical coherence tomography. Br J Ophthalmol (2013) 1.06
Comparison of retinal thickness measurements between three-dimensional and radial scans on spectral-domain optical coherence tomography. Am J Ophthalmol (2009) 1.05
Predictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography study. Br J Ophthalmol (2006) 1.05
Normotension, prehypertension, and hypertension in urban middle-class subjects in India: prevalence, awareness, treatment, and control. Am J Hypertens (2013) 1.04
High glucose-altered gene expression in mesangial cells. Actin-regulatory protein gene expression is triggered by oxidative stress and cytoskeletal disassembly. J Biol Chem (2002) 1.03
Stem cell therapy for retinal disease. Curr Opin Ophthalmol (2012) 1.02
Intraocular pressure outcome of patients with fluocinolone acetonide intravitreal implant for noninfectious uveitis. Ophthalmology (2011) 1.02
Reopening of previously closed macular holes after cataract extraction. Am J Ophthalmol (2007) 1.02
Lipemia retinalis associated with branch retinal vein occlusion. Am J Ophthalmol (2003) 1.01
VESGEN 2D: automated, user-interactive software for quantification and mapping of angiogenic and lymphangiogenic trees and networks. Anat Rec (Hoboken) (2009) 1.01
Retinal and choroidal vascular occlusion after posterior sub-tenon triamcinolone injection. Am J Ophthalmol (2002) 1.00
Evolution of severe lightning maculopathy visualized with spectral domain optical coherence tomography. Ophthalmic Surg Lasers Imaging (2010) 0.98
ISIS-DME: a prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edema. Retina (2008) 0.98
Outcome of fluocinolone acetonide implant (Retisert) reimplantation for chronic noninfectious posterior uveitis. Retina (2008) 0.98
Incidence of new choroidal neovascularization in fellow eyes of patients treated in the MARINA and ANCHOR trials. Am J Ophthalmol (2010) 0.98
Stereotactic low-voltage x-ray irradiation for age-related macular degeneration. Br J Ophthalmol (2010) 0.98
Comparing retinal thickness measurements using automated fast macular thickness map versus six-radial line scans with manual measurements. Ophthalmology (2009) 0.98